User assessment of Norditropin NordiFlex(®), a new prefilled growth hormone pen: a Phase IV multicenter prospective study

BACKGROUND/AIM: In growth disorders, ensuring long-term growth hormone therapy (GHT) remains a challenge that might compromise the clinical outcome. Consequently, strategies aiming at alleviating the burden of daily injection might improve the treatment benefit. The study reported here was performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauber, Maithé, Jaquet, Delphine, Jesuran-Perelroizen, Monique, Petrus, Marc, Bertrand, Anne Marie, Coutant, Regis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668964/
https://www.ncbi.nlm.nih.gov/pubmed/23737664
http://dx.doi.org/10.2147/PPA.S43460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668964/
https://www.ncbi.nlm.nih.gov/pubmed/23737664
http://dx.doi.org/10.2147/PPA.S43460

Ejemplares similares